应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TEVA 梯瓦制药
休市中 12-20 15:59:59 EST
22.08
+0.77
+3.61%
盘后
22.02
-0.07
-0.32%
19:58 EST
最高
22.17
最低
21.11
成交量
1,325万
今开
21.16
昨收
21.31
日振幅
4.97%
总市值
250.52亿
流通市值
249.05亿
总股本
11.35亿
成交额
2.91亿
换手率
1.18%
流通股本
11.28亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读 | 梯瓦制药盘中飙升5.15% 看涨情绪高涨
异动解读 · 12-19
异动解读 | 梯瓦制药盘中飙升5.15% 看涨情绪高涨
梯瓦制药盘中异动 股价大涨5.03%报21.93美元
市场透视 · 12-19
梯瓦制药盘中异动 股价大涨5.03%报21.93美元
美股异动 | 针对溃疡性结肠炎和克罗恩病药物达主要目标 梯瓦制药(TEVA.US)涨超15%
智通财经 · 12-17
美股异动 | 针对溃疡性结肠炎和克罗恩病药物达主要目标 梯瓦制药(TEVA.US)涨超15%
梯瓦制药盘中异动 股价大涨18.35%
市场透视 · 12-17
梯瓦制药盘中异动 股价大涨18.35%
梯瓦制药(TEVA.N)在美国开盘时上涨21%,为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果,达到治疗溃疡性结肠炎和克罗恩病的主要终点。
美港电讯 · 12-17
梯瓦制药(TEVA.N)在美国开盘时上涨21%,为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果,达到治疗溃疡性结肠炎和克罗恩病的主要终点。
梯瓦制药:与赛诺菲合作的药物达到试验目标
老虎资讯综合 · 12-17
梯瓦制药:与赛诺菲合作的药物达到试验目标
梯瓦制药(TEVA.N)美国存托凭证涨幅扩大至19%,公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果,达到治疗溃疡性结肠炎和克罗恩病的主要终点。
美港电讯 · 12-17
梯瓦制药(TEVA.N)美国存托凭证涨幅扩大至19%,公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果,达到治疗溃疡性结肠炎和克罗恩病的主要终点。
医药行业周报:梯瓦 AJOVY三期临床结果积极 用于预防儿童和青少年偏头痛
太平洋证券股份... · 12-06
医药行业周报:梯瓦 AJOVY三期临床结果积极 用于预防儿童和青少年偏头痛
梯瓦制药盘中异动 下午盘股价大涨5.02%报17.49美元
市场透视 · 12-04
梯瓦制药盘中异动 下午盘股价大涨5.02%报17.49美元
梯瓦制药2024财年第三财季实现净利润-4.37亿美元,同比减少653.16%
市场透视 · 11-15
梯瓦制药2024财年第三财季实现净利润-4.37亿美元,同比减少653.16%
异动解读 | 梯瓦制药盘中重挫8.36% 新政府政策不确定性恐增行业压力
异动解读 · 11-07
异动解读 | 梯瓦制药盘中重挫8.36% 新政府政策不确定性恐增行业压力
异动解读 | 梯瓦制药股价盘中重挫逾6% 原因有待观察
异动解读 · 11-06
异动解读 | 梯瓦制药股价盘中重挫逾6% 原因有待观察
梯瓦制药盘中异动 大幅跳水5.01%报17.83美元
市场透视 · 11-06
梯瓦制药盘中异动 大幅跳水5.01%报17.83美元
梯瓦制药公司首席执行官表示将与特朗普政府开展富有成效的合作
Reuters · 11-06
梯瓦制药公司首席执行官表示将与特朗普政府开展富有成效的合作
梯瓦制药盘中异动 下午盘股价大涨5.02%报18.11美元
市场透视 · 10-16
梯瓦制药盘中异动 下午盘股价大涨5.02%报18.11美元
减肥药市场要“变天”?诺和诺德与礼来的“平替”竞争对手出现了
老虎资讯综合 · 09-25
减肥药市场要“变天”?诺和诺德与礼来的“平替”竞争对手出现了
梯瓦制药盘中异动 早盘急速上涨5.02%报17.99美元
自选股智能写手 · 08-14
梯瓦制药盘中异动 早盘急速上涨5.02%报17.99美元
梯瓦制药2024财年第二财季实现净利润-8.45亿美元,同比增加1.97%
自选股智能写手 · 08-05
梯瓦制药2024财年第二财季实现净利润-8.45亿美元,同比增加1.97%
梯瓦制药(TEVA.US)涨超5.4%报17.3美元。消息面上梯瓦制药第二季度营收41.6亿美元市场预估40.5亿美元;调整后EBITDA为11.
智通财经 · 07-31
梯瓦制药(TEVA.US)涨超5.4%报17.3美元。消息面上梯瓦制药第二季度营收41.6亿美元市场预估40.5亿美元;调整后EBITDA为11.
美股异动|梯瓦制药涨超5.4% Q2营收及全年营收指引均超预期梯瓦制药(TEVA.US)涨超5.4%,报17.3美元
格隆汇 · 07-31
美股异动|梯瓦制药涨超5.4% Q2营收及全年营收指引均超预期梯瓦制药(TEVA.US)涨超5.4%,报17.3美元
加载更多
公司概况
公司名称:
梯瓦制药
所属市场:
NYSE
上市日期:
--
主营业务:
Teva Pharmaceutical Industries Limited于1944年2月13日在以色列注册成立。该公司是一家全球性制药公司,致力于帮助世界各地的患者获得负担得起的药物,并从改善健康的创新中受益。该公司的使命是成为仿制药、创新药和生物制药领域的全球领导者,改善患者的生活。该公司在全球开展业务,总部设在以色列,并在美国、欧洲和世界各地的许多其他市场都有重要业务。
发行价格:
--
{"stockData":{"symbol":"TEVA","market":"US","secType":"STK","nameCN":"梯瓦制药","latestPrice":22.08,"timestamp":1734728399986,"preClose":21.31,"halted":0,"volume":13253236,"hourTrading":{"tag":"盘后","latestPrice":22.0201,"preClose":22.09,"latestTime":"19:58 EST","volume":717602,"amount":15851776.5209,"timestamp":1734742707914},"delay":0,"floatShares":1127922922,"shares":1134592397,"eps":-0.856074,"marketStatus":"休市中","marketStatusCode":7,"change":0.77,"latestTime":"12-20 15:59:59 EST","open":21.16,"high":22.17,"low":21.11,"amount":290828957.771056,"amplitude":0.049742,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.856074,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"adjPreClose":21.31,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":21.1,"preClose":21.31,"latestTime":"09:27 EST","volume":47474,"amount":998338.81658,"timestamp":1734704869087},"postHourTrading":{"tag":"盘后","latestPrice":22.0201,"preClose":22.09,"latestTime":"19:58 EST","volume":717602,"amount":15851776.5209,"timestamp":1734742707914},"volumeRatio":0.5891571463384176,"optionData":{"bulkOrders":[{"symbol":"TEVA","call":true,"expireDate":1742529600000,"strike":"22.0","timestamp":1734713894714,"price":1.649999976158142,"volume":19000,"amount":3135000,"type":"+"},{"symbol":"TEVA","call":true,"expireDate":1742529600000,"strike":"17.0","timestamp":1734713894698,"price":5.25,"volume":19000,"amount":9975000,"type":"-"}]},"impliedVol":0.3222,"impliedVolPercentile":0.0357},"requestUrl":"/m/hq/s/TEVA","defaultTab":"news","newsList":[{"id":"1167935318","title":"异动解读 | 梯瓦制药盘中飙升5.15% 看涨情绪高涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1167935318","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167935318?lang=zh_cn&edition=full","pubTime":"2024-12-19 01:56","pubTimestamp":1734544604,"startTime":"0","endTime":"0","summary":"当日盘中,梯瓦制药(TEVA)股价出现罕见大涨,一度飙升5.15%,报21.93美元/股,引发市场广泛关注。\n\n消息面上,目前并未有梯瓦制药相关的重大利好发布。分析人士认为,该公司近期财报表现较为稳定,实现营收43.41亿美元,虽然净利润仍为负值,但公司正逐步恢复增长。另一方面,投资者对于该股长期增长前景充满信心,多家券商给予该股买入评级,也有助于股价上涨。\n\n作为一家全球领先的仿制药制造企业,梯瓦制药在欧美日等主要市场都占据重要地位,除了传统仿制药业务外,公司还在中枢神经、呼吸和肿瘤等多个领域持续拓展创新业务。目前市场预期梯瓦制药仍有一定上涨空间,未来仍需持续关注其经营情况。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 梯瓦制药盘中飙升5.15% 看涨情绪高涨","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"2492312931","title":"梯瓦制药盘中异动 股价大涨5.03%报21.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492312931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492312931?lang=zh_cn&edition=full","pubTime":"2024-12-19 01:49","pubTimestamp":1734544182,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日01时49分,梯瓦制药股票出现异动,股价急速拉升5.03%。截至发稿,该股报21.93美元/股,成交量1151.29万股,换手率1.02%,振幅7.20%。梯瓦制药股票所在的制药行业中,整体跌幅为0.50%。梯瓦一半的销售额来自北美,占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分,提供合同生产服务,并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121901494395ea57df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121901494395ea57df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","TEVA","BK4588","BK4007","BK4566","BK4596","BK4557","BK4584","BK4559"],"gpt_icon":0},{"id":"2492353965","title":"美股异动 | 针对溃疡性结肠炎和克罗恩病药物达主要目标 梯瓦制药(TEVA.US)涨超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492353965","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492353965?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:35","pubTimestamp":1734446107,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周二,梯瓦制药(TEVA.US)股价走高,截至发稿,该股涨超15%,报19.135美元。消息面上,该公司与法国制药商赛诺菲(SNY.US)表示,一项针对溃疡性结肠炎和克罗恩病药物Duvakitug的研究显示,该药物已达到主要目标。去年,两家公司表示合作开发炎症性肠病(IBD)的治疗药物,希望该药物能够成为重磅炸弹级药物,即年销售额至少达到10亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK4596","BK4585","BK4588","BK4566","BK4584","TEVA","BK4559","BK4557"],"gpt_icon":0},{"id":"2492635099","title":"梯瓦制药盘中异动 股价大涨18.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492635099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492635099?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:33","pubTimestamp":1734446025,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时33分,梯瓦制药股票出现波动,股价快速拉升18.35%。截至发稿,该股报19.54美元/股,成交量872.39万股,换手率0.77%,振幅2.97%。梯瓦制药股票所在的制药行业中,整体涨幅为0.35%。梯瓦还销售活性药物成分,提供合同生产服务,并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223345a1f60924&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223345a1f60924&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4596","BK4584","BK4566","BK4007","BK4585","TEVA","BK4557","BK4559"],"gpt_icon":0},{"id":"2492963587","title":"梯瓦制药(TEVA.N)在美国开盘时上涨21%,为2022年7月以来的最大涨幅。公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果,达到治疗溃疡性结肠炎和克罗恩病的主要终点。","url":"https://stock-news.laohu8.com/highlight/detail?id=2492963587","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492963587?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:31","pubTimestamp":1734445896,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4007","BK4584","BK5011","BK4557","BK4559","SNY","TEVA","BK4585","IE00BFXG1179.USD","0O59.UK","BK4588","BK4566","BK4596"],"gpt_icon":0},{"id":"1188765858","title":"梯瓦制药:与赛诺菲合作的药物达到试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1188765858","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188765858?lang=zh_cn&edition=full","pubTime":"2024-12-17 21:01","pubTimestamp":1734440497,"startTime":"0","endTime":"0","summary":"达到治疗结肠炎和克罗恩病的主要终点。","market":"us","thumbnail":"https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2492951465","title":"梯瓦制药(TEVA.N)美国存托凭证涨幅扩大至19%,公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果,达到治疗溃疡性结肠炎和克罗恩病的主要终点。","url":"https://stock-news.laohu8.com/highlight/detail?id=2492951465","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492951465?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:56","pubTimestamp":1734440184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4559","0O59.UK","BK4588","IE00BFXG1179.USD","BK4596","BK4566","SNY","BK4007","BK4557","BK4584","TEVA","BK4585","BK5011"],"gpt_icon":0},{"id":"2489473400","title":"医药行业周报:梯瓦 AJOVY三期临床结果积极 用于预防儿童和青少年偏头痛","url":"https://stock-news.laohu8.com/highlight/detail?id=2489473400","media":"太平洋证券股份...","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489473400?lang=zh_cn&edition=full","pubTime":"2024-12-06 00:00","pubTimestamp":1733414400,"startTime":"0","endTime":"0","summary":"行业要闻:近日,梯瓦公布了其3 期SPACE 研究的积极数据,该研究评估了Ajovy 预防6-17 岁儿童和青少年患者发作性偏头痛的有效性和安全性。Ajovy 是一种人源化的CGRP 单克隆抗体,于2018 获美国FDA 批准上市,作为成人偏头痛的预防性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206133053ab61b245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206133053ab61b245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MHD","BK4559","BK4585","BK4566","BK4584","MMD","BK4557","TEVA","BK4007","BK4596","BK4588"],"gpt_icon":0},{"id":"2488921646","title":"梯瓦制药盘中异动 下午盘股价大涨5.02%报17.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488921646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488921646?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:11","pubTimestamp":1733249473,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日02时11分,梯瓦制药股票出现波动,股价快速上涨5.02%。截至发稿,该股报17.49美元/股,成交量502.257万股,换手率0.44%,振幅3.78%。梯瓦制药股票所在的制药行业中,整体涨幅为0.85%。梯瓦一半的销售额来自北美,占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分,提供合同生产服务,并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204021113971b67c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204021113971b67c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","BK4584","TEVA","BK4559","BK4585","BK4566","BK4588","BK4596"],"gpt_icon":0},{"id":"2483385742","title":"梯瓦制药2024财年第三财季实现净利润-4.37亿美元,同比减少653.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385742?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:00","pubTimestamp":1731600051,"startTime":"0","endTime":"0","summary":"11月15日,梯瓦制药公布财报,公告显示公司2024财年第三财季净利润为-4.37亿美元,同比减少653.16%;其中营业收入为43.41亿美元,同比增加13.40%,每股基本收益为-0.39美元。从资产负债表来看,梯瓦制药总负债353.74亿美元,其中短期债务25.80亿美元,资产负债比为1.19,流动比率为0.90。机构评级:截至2024年11月15日,当前有7家机构对梯瓦制药目标价做出预测,其中目标均价为23.00美元,其中最低目标价为18.00美元,最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000105a237ffda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000105a237ffda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"1178912393","title":"异动解读 | 梯瓦制药盘中重挫8.36% 新政府政策不确定性恐增行业压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1178912393","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178912393?lang=zh_cn&edition=full","pubTime":"2024-11-07 13:09","pubTimestamp":1730956153,"startTime":"0","endTime":"0","summary":"11月6日,梯瓦制药股价盘中重挫逾8%,引发市场广泛关注。公司当季业绩表现强劲,管理层亦对未来增长前景持乐观态度,但投资者担忧特朗普政府未来在医疗保健和制药行业的政策走向存在不确定性,或令制药公司承受更大压力。前期消息显示,梯瓦制药CEO理查德-弗朗西斯先前曾表示,公司预计将与即将上任的特朗普政府开展富有成效的合作,但他承认对特朗普政府的具体政策尚不确定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"1145286895","title":"异动解读 | 梯瓦制药股价盘中重挫逾6% 原因有待观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1145286895","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145286895?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:42","pubTimestamp":1730907762,"startTime":"0","endTime":"0","summary":"11月6日,梯瓦制药股价盘中重挫逾6%,引发市场关注。对于股价暴跌的原因,目前尚无明确说法。一些分析人士认为,投资者对特朗普政府的政策前景存在不确定性,或令梯瓦制药遭到不利影响,从而引发资金流出并拖累股价表现。毫无疑问,特朗普政府的政策导向将是影响梯瓦制药后续股价走势的重要因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"2481984467","title":"梯瓦制药盘中异动 大幅跳水5.01%报17.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481984467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481984467?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:07","pubTimestamp":1730905639,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时07分,梯瓦制药股票出现波动,股价快速下挫5.01%。截至发稿,该股报17.83美元/股,成交量275.219万股,换手率0.24%,振幅7.73%。梯瓦制药股票所在的制药行业中,整体跌幅为1.92%。梯瓦一半的销售额来自北美,占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分,提供合同生产服务,并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230719971a4d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230719971a4d06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4596","BK4007","BK4584","BK4557","BK4559","BK4585","BK4566","TEVA"],"gpt_icon":0},{"id":"2481986298","title":"梯瓦制药公司首席执行官表示将与特朗普政府开展富有成效的合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2481986298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481986298?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:01","pubTimestamp":1730905271,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透耶路撒冷11月6日 - 梯瓦制药工业 首席执行官理查德-弗朗西斯(Richard Francis)周三表示,预计将与即将上任的特朗普政府开展富有成效的合作。\"弗朗西斯在这家以色列制药商发布强劲的第三季度业绩后对路透说:\"我们的工作一如既往,就是与任何政府进行富有成效的合作,我们已经证明了我们能做到这一点,我们也绝对会做到这一点。不过他表示,要等到特朗普上台后才能明确他的医疗保健和制药政策。弗朗西斯还表示,他预计 2025 年公司将 \"一如既往\",品牌药将增长,仿制药业务将继续增长,生物仿制药的销售也将增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TEVA","BK4557","BK4596","BK4584","BK4007","BK4585","BK4559","BK4566"],"gpt_icon":0},{"id":"2475509056","title":"梯瓦制药盘中异动 下午盘股价大涨5.02%报18.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475509056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475509056?lang=zh_cn&edition=full","pubTime":"2024-10-16 02:27","pubTimestamp":1729016873,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日02时27分,梯瓦制药股票出现异动,股价大幅拉升5.02%。截至发稿,该股报18.11美元/股,成交量441.204万股,换手率0.39%,振幅4.61%。梯瓦制药股票所在的制药行业中,整体跌幅为0.61%。梯瓦一半的销售额来自北美,占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分,提供合同生产服务,并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016022754971a071d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016022754971a071d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","BK4588","BK4566","BK4584","TEVA","BK4559","BK4557"],"gpt_icon":0},{"id":"1182104028","title":"减肥药市场要“变天”?诺和诺德与礼来的“平替”竞争对手出现了","url":"https://stock-news.laohu8.com/highlight/detail?id=1182104028","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182104028?lang=zh_cn&edition=full","pubTime":"2024-09-25 17:40","pubTimestamp":1727257205,"startTime":"0","endTime":"0","summary":"梯瓦制药和Sandoz等已推出首批仿制药。","market":"us","thumbnail":"https://static.tigerbbs.com/37608d89603126004448a295afb49463","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/37608d89603126004448a295afb49463"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDZNY","NVO","LLY","TEVA"],"gpt_icon":1},{"id":"2459766106","title":"梯瓦制药盘中异动 早盘急速上涨5.02%报17.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459766106","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459766106?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:20","pubTimestamp":1723648852,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时20分,梯瓦制药股票出现波动,股价急速上涨5.02%。截至发稿,该股报17.99美元/股,成交量699.452万股,换手率0.62%,振幅4.85%。梯瓦制药股票所在的制药行业中,整体涨幅为1.76%。梯瓦一半的销售额来自北美,占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分,提供合同生产服务,并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423205397198bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423205397198bd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","BK4584","BK4588","BK4585","BK4566","TEVA","BK4559"],"gpt_icon":0},{"id":"2457753814","title":"梯瓦制药2024财年第二财季实现净利润-8.45亿美元,同比增加1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457753814","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457753814?lang=zh_cn&edition=full","pubTime":"2024-08-05 00:15","pubTimestamp":1722788131,"startTime":"0","endTime":"0","summary":"8月5日,梯瓦制药公布财报,公告显示公司2024财年第二财季净利润为-8.45亿美元,同比增加1.97%;其中营业收入为41.62亿美元,同比增加7.21%,每股基本收益为-0.75美元。从资产负债表来看,梯瓦制药总负债347.74亿美元,其中短期债务20.94亿美元,资产负债比为1.19,流动比率为0.90。机构评级:截至2024年8月5日,当前有7家机构对梯瓦制药目标价做出预测,其中目标均价为21.29美元,其中最低目标价为16.00美元,最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001537957ca9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001537957ca9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"2455137474","title":"梯瓦制药(TEVA.US)涨超5.4%报17.3美元。消息面上梯瓦制药第二季度营收41.6亿美元市场预估40.5亿美元;调整后EBITDA为11.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455137474","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455137474?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:11","pubTimestamp":1722435105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","TEVA","BK4588","BK4007","BK4566","BK4557","BK4584","BK4559"],"gpt_icon":0},{"id":"2455497132","title":"美股异动|梯瓦制药涨超5.4% Q2营收及全年营收指引均超预期梯瓦制药(TEVA.US)涨超5.4%,报17.3美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455497132","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455497132?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:07","pubTimestamp":1722434859,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4559","BK4585","BK4566","BK4584","BK4557","TEVA","BK4007","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tevapharm.com","stockEarnings":[{"period":"1week","weight":0.3382},{"period":"1month","weight":0.2965},{"period":"3month","weight":0.261},{"period":"6month","weight":0.3019},{"period":"1year","weight":1.085},{"period":"ytd","weight":1.1149}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Teva Pharmaceutical Industries Limited于1944年2月13日在以色列注册成立。该公司是一家全球性制药公司,致力于帮助世界各地的患者获得负担得起的药物,并从改善健康的创新中受益。该公司的使命是成为仿制药、创新药和生物制药领域的全球领导者,改善患者的生活。该公司在全球开展业务,总部设在以色列,并在美国、欧洲和世界各地的许多其他市场都有重要业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.082657},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.0137},{"month":3,"riseRate":0.5,"avgChangeRate":-0.007635},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006929},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.013519},{"month":6,"riseRate":0.538462,"avgChangeRate":0.013933},{"month":7,"riseRate":0.615385,"avgChangeRate":0.035474},{"month":8,"riseRate":0.153846,"avgChangeRate":-0.065595},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.020432},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.021774},{"month":11,"riseRate":0.615385,"avgChangeRate":0.042634},{"month":12,"riseRate":0.538462,"avgChangeRate":0.020215}],"exchange":"NYSE","name":"梯瓦制药","nameEN":"Teva Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"梯瓦制药,TEVA,梯瓦制药股票,梯瓦制药股票老虎,梯瓦制药股票老虎国际,梯瓦制药行情,梯瓦制药股票行情,梯瓦制药股价,梯瓦制药股市,梯瓦制药股票价格,梯瓦制药股票交易,梯瓦制药股票购买,梯瓦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}